GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PuraPharm Corporation Ltd (HKSE:01498) » Definitions » Shiller PE Ratio

PuraPharm (HKSE:01498) Shiller PE Ratio : 0.07 (As of Dec. 11, 2024)


View and export this data going back to 2015. Start your Free Trial

What is PuraPharm Shiller PE Ratio?

As of today (2024-12-11), PuraPharm's current share price is HK$0.60. PuraPharm's E10 for the fiscal year that ended in Dec23 was HK$8.15. PuraPharm's Shiller PE Ratio for today is 0.07.

The historical rank and industry rank for PuraPharm's Shiller PE Ratio or its related term are showing as below:

HKSE:01498' s Shiller PE Ratio Range Over the Past 10 Years
Min: 0.07   Med: 0.09   Max: 0.11
Current: 0.07

During the past 10 years, PuraPharm's highest Shiller PE Ratio was 0.11. The lowest was 0.07. And the median was 0.09.

HKSE:01498's Shiller PE Ratio is ranked better than
99.57% of 465 companies
in the Drug Manufacturers industry
Industry Median: 26.72 vs HKSE:01498: 0.07

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

PuraPharm's adjusted earnings per share data of for the fiscal year that ended in Dec23 was HK$-0.269. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is HK$8.15 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


PuraPharm Shiller PE Ratio Historical Data

The historical data trend for PuraPharm's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PuraPharm Shiller PE Ratio Chart

PuraPharm Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.11

PuraPharm Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.11 -

Competitive Comparison of PuraPharm's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, PuraPharm's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PuraPharm's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PuraPharm's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where PuraPharm's Shiller PE Ratio falls into.



PuraPharm Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

PuraPharm's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=0.60/8.15
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PuraPharm's E10 for the fiscal year that ended in Dec23 is calculated as:

For example, PuraPharm's adjusted earnings per share data for the fiscal year that ended in Dec23 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec23 (Change)*Current CPI (Dec23)
=-0.269/117.2957*117.2957
=-0.269

Current CPI (Dec23) = 117.2957.

PuraPharm Annual Data

Earnings per Share (Diluted) CPI Adj_EPS
201412 70.399 99.707 82.818
201512 0.142 102.015 0.163
201612 0.136 103.225 0.155
201712 0.007 104.984 0.008
201812 0.077 107.622 0.084
201912 -0.872 110.700 -0.924
202012 0.085 109.711 0.091
202112 -0.310 112.349 -0.324
202212 -0.305 114.548 -0.312
202312 -0.269 117.296 -0.269

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


PuraPharm  (HKSE:01498) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


PuraPharm Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of PuraPharm's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


PuraPharm Business Description

Traded in Other Exchanges
N/A
Address
Wireless Centre, Phase One, Unit 201-207, 2nd Floor, Hong Kong Science Park, Tai Po, New Territories, Hong Kong, HKG
PuraPharm Corporation Ltd is a Hong Kong-based Chinese medicine Company. It is engaged in the research and development, production, marketing, and sale of concentrated Chinese medicine granules (CCMG) products marketed under the brand Nong's. The organization provides Chinese medical diagnostic services and operates through several segments: China CCMG, Hong Kong CCMG, Chinese healthcare products, Plantation, and Clinics. The majority of its revenue comes from the Hong Kong CCMG segment, which mainly involves the sale of CCMG products, excluding sales through self-operated clinics in Hong Kong. The group derives revenue from customers located in Hong Kong, Mainland China, and Other countries.
Executives
Chan Yu Ling, Abraham 2101 Beneficial owner
Man Yee Wai, Viola 2202 Interest of your spouse
Fullgold Development Limited 2101 Beneficial owner

PuraPharm Headlines

No Headlines